Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2010
04/22/2010US20100098733 Nitric oxide releasing particles for oral care applications
04/22/2010US20100098715 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders
04/22/2010US20100098713 Drug screening; assay for aldehyde dehydrogenase activity; cancer
04/22/2010US20100098702 Method of treating androgen independent prostate cancer
04/22/2010US20100098701 Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases
04/22/2010US20100098699 Methods of using LRR superfamily genes and proteins
04/22/2010US20100098694 Antibodies to cd40
04/22/2010US20100098691 Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
04/22/2010US20100098690 Pharmaceutical composition
04/22/2010US20100098689 4-1 bb ligand in inflammatory diseases
04/22/2010US20100098688 Method for diagnosis of a disease involving an anti-at1-receptor antibody
04/22/2010US20100098685 Use of Inhibitors of Toll-Like Receptors in the Prevention and Treatment of Hypercholesterolemia and Hyperlipidemia and Diseases Related Thereto
04/22/2010US20100098684 Biomarkers and methods for detecting and treating spinal and joint pain
04/22/2010US20100098683 MUC1 and Galectin-3
04/22/2010US20100098682 Effect of Bri Proteins on Ass Production
04/22/2010US20100098678 Methods of Treatment of Mitochondrial Disorders
04/22/2010US20100098677 Methods and Devices for Epithelial Protection During Photodynamic Therapy
04/22/2010US20100098676 Synergistic anti-inflammatory and antioxidant dietary supplement compositions
04/22/2010US20100098663 Methods of Inhibiting Tumor Cell Proliferation with FoxM1 siRNA
04/22/2010US20100098662 Treatment of liver diseases in which iron plays a role in pathogenesis
04/22/2010US20100098661 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
04/22/2010US20100098654 Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
04/22/2010US20100098642 Optimised formulation of tobramycin for aerosolization
04/22/2010US20100098640 Multidentate Pyrone-Derived Chelators for Medicinal Imaging and Chelation
04/22/2010US20100098639 Compositions and Methods for Convection Enhanced Delivery of High Molecular Weight Neurotherapeutics
04/22/2010US20100098638 RIP140 Regulation of Diabetes
04/22/2010US20100098633 Selective seprase inhibitors
04/22/2010US20100098632 Hydroxyapatite particles
04/22/2010US20100098631 Novel-2-Heteroaryl Substituted Indoles 695
04/22/2010US20100098630 Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides
04/22/2010US20100098629 Novel Amides Acting on the Adenosine Receptors
04/22/2010US20100095963 Pharmaceutical compositions
04/22/2010DE202008016399U1 Progesteron in homöopathischer Dosierung Progesterone in homeopathic doses
04/22/2010DE202004021680U1 Feste pharmazeutische Zusammensetzung A solid pharmaceutical composition
04/22/2010DE102008052013A1 New 4-(4-cyano-2-thioaryl)dihydropyrimidinone compounds are neutrophil elastase inhibitors useful to treat or prevent e.g. pulmonary arterial hypertension, chronic obstructive pulmonary disease, acute lung injury, or cystic fibrosis
04/22/2010DE102008051783A1 Valsartan enthaltende Tablette Valsartan containing tablet
04/22/2010CA2822167A1 Pharmaceutical topical compositions
04/22/2010CA2777233A1 Compositions and methods for treating varicose veins
04/22/2010CA2743828A1 Fas/fasl or other death receptor targeted methods and compositions for killing tumor cells
04/22/2010CA2741069A1 Inhibitors of mitosis for increasing apoptosis in therapy
04/22/2010CA2741060A1 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders
04/22/2010CA2741029A1 Spiro-oxindole compounds and their use as therapeutic agents
04/22/2010CA2741024A1 Spiro-oxindole compounds and their use as therapeutic agents
04/22/2010CA2740969A1 Novel thiophene compounds for use in theraphy
04/22/2010CA2740885A1 Fused ring heteroaryl kinase inhibitors
04/22/2010CA2740874A1 Methods of reducing small, dense ldl particles
04/22/2010CA2740785A1 Modulation of factor 11 expression
04/22/2010CA2740773A1 Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
04/22/2010CA2740696A1 Heterocyclic benzimidazoles as trpm8 modulators
04/22/2010CA2740614A1 New 2-amidothiadiazole derivatives
04/22/2010CA2740610A1 Methods and compositions for improving cognitive function
04/22/2010CA2740570A1 Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-iv, and other antidiabetic or antiobesity agents as active ingredients
04/22/2010CA2740568A1 Compositions and methods for treating or preventing hypoxic or ischemic injury
04/22/2010CA2740525A1 Heterocyclyl and cycloalkyl substituted thieno[2,3-d]pyrimidine and their use as adenosine a2a receptor antagonists
04/22/2010CA2740484A1 S1p receptors modulators and their use thereof
04/22/2010CA2740471A1 Morpholinopurine derivatives
04/22/2010CA2740424A1 Amines and sulfoxides of thieno[2,3-d]pyrimidine and their use as adenosine a2a receptor antagonists
04/22/2010CA2740418A1 Salicylic acid composition
04/22/2010CA2740413A1 Heteroaryl substituted thieno[2,3-d]pyrimidine and their use as adenosine a2a receptor antagonists
04/22/2010CA2740412A1 Phenyl substituted thieno[2,3-d]pyrimidines and their use as adenosin a2a receptor antagonists
04/22/2010CA2740411A1 Heteroaryl and phenyl substituted thieno[2,3-d]pyrimidines and their use as adenosine a2a receptor antagonists
04/22/2010CA2740410A1 Phenyl and heteroaryl substituted thieno[2,3-d] pyrimidines and their use as adenosine a2a receptor antagonists
04/22/2010CA2740408A1 Amides of thieno[2,3-d]pyrimidine and their use as adenosine a2a receptor antagonists
04/22/2010CA2740406A1 Methylene amines of thieno[2,3-d]pyrimidine and their use as adenosine a2a receptor antagonists
04/22/2010CA2740360A1 Method for treatment of copd and other pulmonary diseases
04/22/2010CA2740333A1 Process for the preparation of enantiomerically enriched proton pump inhibitors
04/22/2010CA2740317A1 Etoposide and doxorubicin conjugates for drug delivery
04/22/2010CA2739954A1 Methods of treating pulmonary disorders with liposomal amikacin formulations
04/22/2010CA2739936A1 Pharmaceutical compositions with attenuated release of phenolic opioids
04/22/2010CA2739901A1 S1p receptors modulators
04/22/2010CA2739888A1 Spirocyclic gpr40 modulators
04/22/2010CA2739701A1 Antimicrobial compositions
04/22/2010CA2739545A1 Method of determining a phosphorus binder dosage for a dialysis patient
04/22/2010CA2739491A1 Azine derivatives and methods of use thereof
04/22/2010CA2739490A1 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
04/22/2010CA2739488A1 Fused heteroaryl diamide compounds useful as mmp-13 inhibitors
04/22/2010CA2739466A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/22/2010CA2739344A1 Phenethylamide derivatives and their heterocyclic analogues
04/22/2010CA2739148A1 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor
04/22/2010CA2739060A1 Fused-ring derivative and medical application of same
04/22/2010CA2739058A1 Fused heterocyclic derivative and use thereof for medical purposes
04/22/2010CA2738929A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
04/22/2010CA2738872A1 New benzimidazole derivatives
04/22/2010CA2738849A1 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
04/22/2010CA2738806A1 Nicotinic acetylcholine receptor ligands and the uses thereof
04/22/2010CA2738757A1 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury
04/22/2010CA2738614A1 Drop pill for treating coronary heart disease and preparation thereof
04/22/2010CA2738609A1 Piperidine compounds, pharmaceutical composition comprising the same and its use
04/22/2010CA2738384A1 Pharmaceutical topical compositions
04/22/2010CA2738367A1 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
04/22/2010CA2737855A1 Di-vanilloyl and tri-vanilloyl derivatives for use in anti-cancer therapy
04/22/2010CA2737775A1 Trpv1 antagonists
04/22/2010CA2737768A1 Trpv1 antagonists
04/22/2010CA2737754A1 Co-crystals of tramadol and nsaids
04/22/2010CA2736409A1 Benzoquinoline inhibitors of vesicular monoamine transporter 2
04/22/2010CA2736335A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
04/22/2010CA2736206A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors
04/22/2010CA2735834A1 A medicinal product and treatment
04/22/2010CA2735477A1 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
04/22/2010CA2641541A1 Methods for inducing programmed cell death
1 ... 2299 2300 2301 2302 2303 2304 2305 2306 2307 2308 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 ... 7860